Approaches towards Therapy and Management of Keratoconus
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 4, 2021, Pages. 14344 - 14353
Received 05 March 2021; Accepted 01 April 2021.
Approaches towards Therapy and Management of Keratoconus
Suprava Das1, Anita Minj1, Swati Samant1,SaurjyaRanjan Das2,Jatindra Nath Mohanty3*
1
Department of Ophthalmology, IMS and Sum hospital, SOA deemed to be University,
Bhubaneswar, India
2
Department of Anatomy, IMS and Sum hospital, SOA deemed to be University, Bhubaneswar,
India
3
Department of Medical Research Laboratory, IMS and Sum hospital, SOA deemed to be
University, Bhubaneswar, India
Corresponding author
Jatindra Nath Mohanty, Assistant Professor, Department of Medical Research Laboratory,
IMS and Sum hospital, SOA deemed to be University, Bhubaneswar, India
Mail id – jatindranathmohanty@soa.ac.in
Abstract
The previous 20 years have seen a blast in our insight into keratoconus, joined by an extreme
change of the board choices. A 2-hit speculation proposes a fundamental hereditary inclination
combined with outer ecological elements, including eye scouring and atopy. The variable
pervasiveness and regular history have been exceptional characterized remembering huge cone
movement for middle age. Consequently, current administration should incorporate early
conclusion, standard checking, and treatment of natural cofactors. Scenes and contact focal
points stay basic to the optical administration of keratoconus. Intrastromal corneal ring portions
have been progressively utilized, giving improvement in the corneal shape, rectified visual
keenness, and contact focal point wear. Be that as it may, similar to contact focal points,
intrastromal corneal ring portions don't treat the hidden sickness measure. In this manner, current
methodologies should likewise think about medicines to limit keratoconus movement. Luckily,
there is expanding proof that corneal collagen crosslinking will end or slow movement much of
the time. Until generally as of late, infiltrating keratoplasty was the favored intercession for
cutting edge keratoconus, with long haul achievement in the locale of 90%; be that as it may, the
most serious danger of disappointment stays endothelial allograft dismissal. Profound foremost
lamellar keratoplasty has arisen in the new thousand years as a favored way to deal with ration
the host endothelium and dodge dismissal. In any case, the general prevalence of profound
foremost lamellar keratoplasty contrasted and entering keratoplasty, as far as optical and
endurance benefits are as yet discussed. This viewpoint gives an outline of our present
information on keratoconus and current administration choices. A stage stepping stool way to
deal with overseeing keratoconus is plot to furnish the specialist with a contemporary
administration worldview.
Key words: Keratoconus, Conical corneal ectasia, Contemporary management, Therapy
http://annalsofrscb.ro 14344Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 4, 2021, Pages. 14344 - 14353
Received 05 March 2021; Accepted 01 April 2021.
Introduction
Keratoconus is an infection element of the optical framework, described by a cone shaped
corneal ectasia. The ectasia comprises in strange diminishing of focal and paracentral areas of
the cornea, just as reformist focal deformity bringing about huge sporadic astigmatism. The
highest point of the distending cone that corneal design might be near the visual hub or beneath
and nasal of that. The sickness shows during puberty, trailed by moderate reformist course,
despite the fact that it is conceivable to settle whenever. In 85% of cases the two eyes are
influenced, however the seriousness of the assault can introduce huge deviation [1]. Frequently
in keratoconus a positive family ancestry is available, and in certain patients the legacy seems to
assume a significant part, yet the character wherein the sickness is acquired is yet to be
explained. The illness has been portrayed related to an assortment of fundamental infections are
primarily atopic sicknesses (atopic dermatitis), endocrine problems, Down's condition, Marfan
disorder and visual illnesses, for example, vernal conjunctivitis, retinitis pigmentosa, inherent
amaurosis of Lieber and ectopic [2]. Bearing hard contact focal points and scouring the eyes
have been proposed as potential inclining factors [3].
The utilization of Intracorneal ring fragments (ICRS), excimer laser , phakic intraocular focal
points (IOLs) and evolvement of DALK methods have all made huge commitments in giving
powerful treatment to all phases of KC. In spite of the fact that strategies have been created to
treat more slender or more extreme corneas, [4,5] corneas more slender than 400µm or more
extreme than 58D may not be qualified for UV cross-connecting. The new strategy of Bowman
Layer Transplantation has been the most recent expansion in the armamentarium to handle
progressed KC. Treatment of KC should be individualized. Various models to consider the more
appropriate strategy or treatment for any patient incorporate refraction, age, level of diminishing,
unpredictable astigmatism, and presence or nonappearance of scarring.
Keratoconus
Despite the fact that keratoconus was portrayed by Dr Benedict Duddell in 1736, the early
writing is befuddling a result of the assortment of names utilized for the illness, including,
hyperkeratosis, ochlodes, sugar-portion cornea, cornea conica, staphylomapellucidum,
keratoncus, and keratoconus, to give some examples. Progressively all around portrayed
throughout the following 100 years, regardless, impediments of innovation and comprehension
of the infection drove Pickford (1844) to astringently note, "there is presumably no illness to
which the eye is subject, heretofore so insubordinate to medication, so obstinate in its
temperament, and, simultaneously, so deadly to vision, as tapered cornea; [6] and not one, the
pathology and treatment of which are so little understood."1–Subsequently, Nottingham, in his
270-page masterpiece (1854), depicted keratoconus with clearness and extraordinary precision
for the time, including parts of corneal diminishing and shape, reformist refractive changes,
optical rectification, and treatment—albeit corneal transplantation was as yet in its infancy[7].
http://annalsofrscb.ro 14345Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 4, 2021, Pages. 14344 - 14353
Received 05 March 2021; Accepted 01 April 2021.
From those early spearheading days, where much got the hang of composing lay in the keen
perception and clinical experience of the creator, we have advanced to a time of high-innovation
investigation and close moment data sharing. In fact, the previous 20 years have seen a blast in
our insight into, and capacity to analyze, keratoconus with the complete companion assessed
writing on keratoconus developing from roughly 750 articles up to and including 1994, to almost
5000 articles by 2014 (PubMed got to twentieth December 2014;
www.ncbi.nlm.nih.gov/pubmed)[8].
The executives Strategies
This expanding clinical and logical writing has been joined by extremist change of the executives
alternatives for keratoconus. Previously, clinicians have commonly acknowledged various key
"realities" corresponding to keratoconus: (1) it is a reformist corneal ectasia, (2) the etiology is
noninflammatory, (3) movement is joined by expanding sporadic astigmatism, conceivable
scarring or hydropscorneae, (4) at last, it could be related with loss of best-amended vision and
the chance of corneal transplantation, and (5) the etiology is not entirely seen yet has hereditary
and ecological components.3 However, over a century after its extensive depiction by
Nottingham,2 the specific reason for the illness stays to be completely explained, and a portion
of these "realities, for example, the noninflammatory idea of the sickness, might be tested later
on. Surely, the etiology is likely multifactorial or it is possible that the keratoconus aggregate
addresses a last regular pathway for various diverse illness measures in the cornea.
Progressively, a "2-hit theory" of the illness is for the most part acknowledged with a basic
hereditary inclination to keratoconus affected by outside ecological variables, including eye
scouring and atopy [3–6] Any examination of sickness the board should think about etiology,
pervasiveness, and common history, particularly in a generally phenomenal infection like
keratoconus. The commonness of keratoconus has been accounted for to shift from 50
cases per 100,000 and is habitually cited as roughly 1:2000. On the other hand, in high-
pervasiveness regions, for example, the Middle East, geographical highlights of keratoconus
have been noted in 3.3% of a youthful grown-up populace. This wide variety in detailed
predominance is to some degree because of various hereditary inclination, contrasting openness
to cofactors, and maybe in particular extraordinary symptomatic models. Unquestionably,
analysis has moved from conventional procedures, for example, retinoscopy, refraction, cut light
appraisal, and Placido circle to contemporary methods including geography, tomography, higher-
request aberrometry, front fragment optical intelligibility tomography, and biomechanical
evaluation [9, 10].
A traditionalist and moderate administration worldview
Regarding treatment ideal models, the proof base proposes that traditionalist administration
should remember guidance for connection to evasion of eye scouring and solution of skin
specialists where required, including pole cell stabilizers, antihistamines, and joined agents.6
Topical greases may likewise be helpful in atopy related with dry eye indications, and additive
http://annalsofrscb.ro 14346Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 4, 2021, Pages. 14344 - 14353
Received 05 March 2021; Accepted 01 April 2021.
free specialists ought to consistently be utilized where incessant skin drug of any structure is
being mulled over.
As recently noticed, a family ancestry has been set up for a long time in keratoconus;
notwithstanding, the specific component of legacy is unsure in light of the fact that regularly
10% or less relatives clinically display the sickness albeit geographical cases are more normal
[3,4,6,9–11]. Numerous investigations propose an autosomal-predominant example of legacy
with variable phenotypic articulation, despite the fact that others have recommended a non-
Mendelian method of legacy.
Considering this fluctuation in legacy, routine hereditary testing isn't justified in influenced
people, albeit in enormous investigations, genomewide affiliation examines are probably going
to give more information soon. Notwithstanding, tomographic screening of relatives might be
valuable in getting early sickness.
Unavoidably, a few subjects can't be overseen moderately as a result of the regular history of the
infection. Keratoconus for the most part starts in adolescence and has a variable movement,
being steady, quick, or discontinuous from pubescence to the fifth decade when movement
ordinarily eases back. In any case, eventually, around 20% of subjects may expect keratoplasty
to restore vision. Curiously, cautious thought of the writing frustrates the broadly held
discernment that keratoconus settles during the 40s. Without a doubt, keratoconus might be
viewed as an infection that "never rests" with the Collaborative Longitudinal Evaluation of
Keratoconus study uncovering a mean increment of 1.6 diopters (D) of ebb and flow in the level
corneal meridian more than 8 years, with 24% of eyes displaying >3.0 D movement.
Significantly, this perception was in a gathering with a mean time of 39.3 years on passage to the
examination. In an investigation of subjects with keratoconus alluded to a public emergency
clinic corneal help in the United Kingdom at a mean age of 23 years, 67% proceeded with
fruitful contact focal point wear yet 31% advanced to entering keratoplasty (PK) at a mean of 8.5
years after diagnosis.26 Studies from New Zealand have uncovered keratoconus as the most
widely recognized sign for keratoplasty in 1991 to 1999 (45.6%) and 2000 to 2009 (41.1%). Due
to the danger of movement to keratoplasty, key targets in making treatment ideal models for
keratoconus should incorporate early finding, customary checking, and utilization of mediations
to slow or forestall illness progression[12,13,14].
Evolution of corneal collagen crosslinking
Until the start of the new thousand years, the treatment worldview for keratoconus was basically
a straightforward 2-alternative interaction: (1) if the keratoconus was steady or shown negligible
movement, with great best-amended visual keenness (BCVA), the subject would be overseen by
display or unbending gas-porous contact focal points and any visual atopy or eye scouring
treated with skin medicine, (2) if the keratoconus was progressed or connected with scarring or
decreased BCVA, the subject would be offered PK, and conceivable ensuing visual remedy by
http://annalsofrscb.ro 14347Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 4, 2021, Pages. 14344 - 14353
Received 05 March 2021; Accepted 01 April 2021.
contact focal points. Nonetheless, there has been a blast in choices for treating keratoconus in the
previous 20 years, with the end goal that such treatment plans are currently obsolete. The
primary objectives of treatment of keratoconus are presently to expand visual keenness and
forestall movement of the disease.
Moderate and careful ways to deal with keratoconus the board should now incorporate an
enormous number of choices, including displays, contact focal points, ordinary tomographic
survey to identify movement, treatments to lessen eye scouring, collagen crosslinking (CXL),
intracorneal ring fragments, surface-based keratorefractive laser techniques, phakic intraocular
focal points (IOLs), waterfall extraction with toric IOLs in more seasoned subjects, and PK or
profound foremost lamellar keratoplasty (DALK) in cutting edge illness [15-17].
Premier among the significant changes in the administration of keratoconus have been the turn of
events and fast far and wide acknowledgment of corneal CXL utilizing riboflavin as a
photosensitizer joined with UV-A light exposure.30–33 Indeed, as ahead of schedule as 2006,
Wollensak composed that crosslinking therapy of reformist keratoconus brought "new
expectation" to an illness heretofore frustratingly hard to oversee without major careful
intercession in 21% of cases. The Dresden gathering, in a 6-year follow-up of 241 eyes, noticed a
mean most extreme keratometry decrease of 1.9 D with some improvement in astigmatism and
BCVA.31 Wittig-Silva et al in Melbourne, in one of the not many distributed randomized
controlled preliminaries (RCT), additionally noticed a decrease in greatest keratometry and an
inclination to improved remedied visual sharpness. In a RCT by the creator and associates in
New Zealand, "at two years a mean contrast of 2.2 D was identified in greatest keratometry in
treated versus the contralateral untreated, control eyes" (unpublished information). This RCT
remembered for vivo confocal microscopy, which featured total loss of the subbasal nerve plexus
and front stromal keratocytes after treatment; notwithstanding, by year after CXL, there was
finished recovery of the corneal nerve plexus and repopulation of the foremost stroma by
keratocytes. Hyperreflective groups were noted in the district delineating the limit among treated
and untreated stroma. Eminently, CXL has been grounded and accessible inside the private area
since 2007, including acknowledgment by wellbeing back up plans, and furthermore opened up
in the New Zealand general wellbeing area in 2014 [18-21].
Strangely, the distributed proof base that underpins the utilization of CXL in keratoconus, albeit
broad, isn't of as high caliber as one would expect.33 Although around 500 references are
recognized by electronic hunts, a new Cochrane survey (2015) of CXL notes, "Notwithstanding
the various planned and review examines accessible in the writing and the way that CXL is by all
accounts acknowledged worldwide as an advancement treatment in the administration of
keratoconus, proof is restricted because of the absence of appropriately directed RCTs." Indeed,
the writers of this Cochrane audit note that of 51 full-text reports got to consider for
consideration in the audit, just 8 reports were reasonable, including 3 RCTs that selected a sum
http://annalsofrscb.ro 14348Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 4, 2021, Pages. 14344 - 14353
Received 05 March 2021; Accepted 01 April 2021.
of just 225 eyes. Finishes of this Cochrane survey incorporated the accompanying: treated eyes
had a less steep cornea—roughly 2.0 D, uncorrected visual sharpness improved by around 2 lines
or 10 letters, and no investigations announced deficiency of 0.2 logarithm of the base point of
goal visual keenness. Be that as it may, information on corneal thickness were conflicting, and
antagonistic impacts of CXL treatment were normal yet generally of low clinical
significance[22].
Keratoplasty in keratoconus
Progressively, while thinking about keratoplasty for cutting edge keratoconus, ophthalmologists
decide on DALK instead of PK on account of the apparent preferences of the previous strategy.
The fundamental preferences of DALK over PK incorporate that it is principally an extraocular
strategy, effective corticosteroids can be utilized for a more limited period diminishing the
danger of waterfall and raised intraocular pressure, there is no danger of endothelial dismissal
and in this manner generally follow-up and the board ought to be less complex than PK, and on a
basic level, there ought to be a more prominent possibility of long haul allograft endurance. In
any case, a portion of these apparent points of interest are not also upheld by the writing as much
as the specialist's energy for the method. Impediments incorporate an in fact requesting and
persistently advancing DALK strategy; restrictions in corneas with scar, neovascularization, or
past intense hydrops; and time–cost and financial practicality of DALK contrasted and PK in
certain areas.
Albeit the creators' favored first-line way to deal with transplantation in keratoconus is to think
about DALK, it should in any case be recalled that PK is a very grounded method, and
achievement in keratoconus is especially high. The Australian Corneal Graft Registry noticed
that PK unite endurance for keratoconus cases is 89% at 10 years with a mean endurance of 18.2
years. In a longitudinal investigation of 125 patients in Japan, with a mean age of 25 years at the
hour of PK, Fukuoka et al detailed a 10-year and 20-year unite endurance of 99% and 97%,
separately [23-25].
Remarkably, DALK is related with a huge careful expectation to absorb information, and a
report of 2372 keratoplasties (roughly 20% DALK) for keratoconus, performed by an assortment
of specialists in the United Kingdom, distinguished that DALK had double the danger of
disappointment contrasted and PK and that 19% fizzled in the initial 30 days (contrasted and 2%
PK). Be that as it may, at 3-year postsurgery, endurance rates were comparative (DALK 92%
versus PK 94%). In spite of the fact that there was no distinction in astigmatism, PK eyes were
bound to acquire 20/20 (22% DALK versus 33% PK) and DALK was related with a more
prominent possibility of >3.0 D of nearsightedness.
In any case, the advantages as far as dodging the danger of endothelial dismissal are significant:
contrasting 142 DALK and 142 PK strategies uncovered that albeit the DALK cases grew low-
level stromal (11%) and epithelial dismissal (1%), the PK cases showed stromal/epithelial
dismissal in 2% yet possibly sight-undermining endothelial dismissal in 15% of eyes. Visual
http://annalsofrscb.ro 14349Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 4, 2021, Pages. 14344 - 14353
Received 05 March 2021; Accepted 01 April 2021.
hypertension was additionally substantially more typical in PK (26%) contrasted and DALK
(6%). Strikingly, assumed corticosteroid-related height of intraocular pressure has been
accounted for in up to 35% of keratoconus eyes after keratoplasty; along these lines, the
advantage of momentary steroid inclusion might be critical [26-28].
In Auckland, New Zealand, "DALK expanded from under 5% of keratoplasty methods in 2000
to 16% by 2009—with 60.3% of these DALKs for keratoconus" (unpublished information). In a
comparative period (1999–2009), signs for corneal join a medical procedure in the United
Kingdom additionally changed fundamentally with the quantity of PK systems for keratoconus
dropping from 453 to 322, though the quantity of DALK techniques expanded >5-crease from 45
out of 1999–2000 to 226 out of 2008–2009, that is, 40% of all keratoplasty strategies for
keratoconus. Interestingly, the Eye Bank Association of America report for the time frame 2011
to 2013 featured that PK numbers were steady yet of very nearly 7000 keratoplasties for
keratoconus in 2013, just 9.8% were DALK techniques proposing generally moderate take-up of
DALK in the United States. Luckily, as featured in the prior areas, PK stays a decent long haul
choice for keratoconus [29].
Future options in keratoconus
The hidden infection measure in keratoconus is a long way from completely settled. As
effectively sketched out, there is an unmistakable hereditary inclination related with changes that
incorporate corneal diminishing and protrusion.3,5,6 A 2-hit theory that incorporates hereditary
inclination and natural factors, for example, eye scouring is progressively accepted.3,4,23
Although by and large idea to be noninflammatory, ongoing proof proposes that a low-level
incendiary segment might be available, and this since quite a while ago held assumption may
should be reconsidered [30]. Subsequently, effective specialists notwithstanding pole cell
stabilizers, antihistamines, and oils may later on likewise incorporate specialists, for example,
effective cyclosporine.
As far as careful methodology, CXL may forestall movement of the infection, and keratoplasty
may supplant the seriously sick focal cornea in cutting edge keratoconus, but since the hidden
cycles stay mysterious, no methodologies at present opposite or fix the sickness. Surely,
notwithstanding broad examination of the biomechanical properties of the cornea in keratoconus,
the cut off among ordinary and early infection is yet to be well established.51 The basic structure
squares of the cornea depend on typical keratocyte capacity, and it has been proposed that
apoptosis is a method of cell passing in keratoconus that may prompt loss of keratocytes and
therefore bargain of the corneal construction. In keratoconic eyes, without past contact focal
point wear, in vivo confocal microscopy has affirmed measurably huge decrease in both
foremost and back keratocyte thickness. Theoretically, in early illness, the addition of begetter
keratocytes developed from giver corneas, by infusion or through femtosecond laser–created
channels into keratoconic corneas could permit repopulation of the cornea with sound cells—yet
http://annalsofrscb.ro 14350Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 4, 2021, Pages. 14344 - 14353
Received 05 March 2021; Accepted 01 April 2021.
evading corneal transplantation [31]. Early work on this idea has just been finished, and
specialists inside the New Zealand National Eye Center have shown confirmation of idea with
the repopulation of decellularizedkeratoconus corneas with keratocyte ancestor cells[32].
Conclusion
The turn of events and expansion of more current imaging strategies in the early analysis and the
board of KC has positively brought about a force to handle this genuine corneal pathology before
it gets progressed enough to require PK. The noteworthy development of different strategies used
to treat KC has indicated gigantic headway in the previous decade. With the possibility to adjust
the common history of KC and potentially even stop illness movement utilizing techniques like
CXL and BL Transplantation and with the recently evolved methods to give most ideal optical
results to these patients, need for corneal transfer in KC may turn into a relic of times gone by.
Utilization of consolidated systems and promising progressing research in administration of KC
has gone about as an impetus for ophthalmologists everywhere on the world to give most ideal
visual results to these patients. Later on, most likely new treatment strategies will have logical
establishments in sub-atomic instruments which can stop the underlying beginning of ectasia.
Reference
1. Caporossi A, Mazzotta C, Baiocchi S&Caporossi T.(2010) Long-term results of riboflavin
ultraviolet a corneal collagen cross-linking for keratoconus in Italy: the Siena eye cross
study. Am J Ophthalmol 149 (4:585–593. Filippello M, Stagni E &O'Brart D.(2012)
Transepithelial corneal collagen crosslinking: bilateral study. J Cataract Refract Surg38
2:283– 291.
2. Gkika M, Labiris G&Kozobolis V. (2011) Corneal collagen cross-linking using riboflavin
and ultraviolet-A irradiation: a review of clinical and experimental studies. IntOphthalmol
31(4):309- 19.
3. Gore DM, Shortt AJ & Allan BD.(2013) New clinical pathways for keratoconus. Eye
(Lond) 27(3):329- 39.
4. Haddad W, Fadlallah A, Dirani A, Rami El H, Fahd D, Khanafer D&Fahed S. (2012)
Comparison of 2 types of intrastromal corneal ring segments for keratoconus. J Cartaract
Refract Surg 38(7):1214– 1221 .
5. Nottingham J. Practical Observations on Conical Cornea: And on the Short Sight, and
Other Defects of Vision Connected With It. London, United Kingdom: J Churchill; 1854.
6. McGhee CN. 2008 Sir Norman McAlister Gregg Lecture: 150 years of practical
observations on the conical cornea—what have we learned? Clin Experiment Ophthalmol.
2009;37:160–176.
7. Burdon KP, Vincent AL. Insights into keratoconus from a genetic perspective.
ClinExpOptom. 2013;96:146–154.
http://annalsofrscb.ro 14351Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 4, 2021, Pages. 14344 - 14353
Received 05 March 2021; Accepted 01 April 2021.
8. Vincent AL, Jordan CA, Cadzow MJ, et al.. Mutations in the zinc finger protein gene,
ZNF469, contribute to the pathogenesis of keratoconus. Invest Ophthalmol Vis Sci.
2014;55:5629–5635.
9. Gomes JA, Tan D, Rapuano CJ, et al.. Global consensus on keratoconus and ectatic
diseases. Cornea. 2015;34:359–369.
10. Hashemi H, Khabazkhoob M, Fotouhi A. Topographic Keratoconus is not Rare in an
Iranian population: the Tehran Eye Study. Ophthalmic Epidemiol. 2013;20:385–391.
11. Piñero DP, Nieto JC, Lopez-Miguel A. Characterization of corneal structure
in keratoconus. J Cataract Refract Surg. 2012;38:2167–2183.
12. Rabinowitz YS, Garbus J, McDonnell PJ. Computer-assisted corneal topography in family
members of patients with keratoconus. Arch Ophthalmol. 1990;108:365–371.
13. Levy D, Hutchings H, Rouland JF, et al..Videokeratographic anomalies in
familial keratoconus. Ophthalmology. 2004;111:867–874.
14. Karimian F, Aramesh S, Rabei HM, et al.. Topographic evaluation of relatives of patients
with keratoconus. Cornea. 2008;27:874–878.
15. Lim L, Wei RH, Chan WK, et al.. Evaluation of keratoconus in Asians: role of Orbscan II
and Tomey TMS-2 corneal topography. Am J Ophthalmol. 2007;143:390–400.
16. Sonmez B, Doan MP, Hamilton DR. Identification of scanning slit-beam topographic
parameters important in distinguishing normal from keratoconic corneal morphologic
features. Am J Ophthalmol. 2007;143:401–408.
17. Belin MW, Villavicencio OF, Ambrósio RR Jr. Tomographic parameters for the detection
of keratoconus: suggestions for screening and treatment parameters. Eye Contact Lens.
2014;40:326–330.
18. Hashemi H, Khabazkhoob M, Yazdani N, et al.. The prevalence of keratoconus in a young
population in Mashhad, Iran. Ophthalmic Physiol Opt. 2014;34:519–527.
19. Gordon-Shaag A, Millodot M, Essa M, et al.. Is consanguinity a risk factor
for keratoconus? Optom Vis Sci. 2013;90:448–454.
20. Edwards M, McGhee CN, Dean S. The genetics of keratoconus. Clin Experiment
Ophthalmol. 2001;29:345–351.
21. Rahi A, Davies P, Ruben M, et al.. Keratoconus and coexisting atopic disease. Br J
Ophthalmol. 1977;61:761–764.
22. Georgiou T, Funnell CL, Cassels-Brown A, et al.. Influence of ethnic origin on the
incidence of keratoconus and associated atopic disease in Asians and white patients. Eye
(Lond). 2004;18:379–383.
23. Weed KH, MacEwen CJ, Giles T, et al.. The Dundee University
Scottish Keratoconus study: demographics, corneal signs, associated diseases, and eye
rubbing. Eye (Lond). 2008;22:534–541.
24. Bawazeer AM, Hodge WG, Lorimer B. Atopy and keratoconus: a multivariate analysis. Br
J Ophthalmol. 2000;84:834–836.
http://annalsofrscb.ro 14352Annals of R.S.C.B., ISSN:1583-6258, Vol. 25, Issue 4, 2021, Pages. 14344 - 14353
Received 05 March 2021; Accepted 01 April 2021.
25. McMonnies CW, Boneham GC. Keratoconus, allergy, itch, eye-rubbing and hand-
dominance. ClinExpOptom. 2003;86:376–384.
26. McMonnies CW. Mechanisms of rubbing-related corneal trauma in keratoconus. Cornea.
2009;28:607–615.
27. Kriszt A, Losonczy G, Berta A, et al.. Segregation analysis suggests that keratoconus is a
complex non-Mendelian disease. ActaOphthalmol. 2014;92:e562–568.
28. Wagner H, Barr JT, Zadnik K. Collaborative Longitudinal Evaluation
of Keratoconus (CLEK) Study: methods and findings to date. Cont Lens Anterior Eye.
2007;30:223–232.
29. Weed KH, McGhee CN. Referral patterns, treatment management and visual outcome
in keratoconus. Eye (Lond). 1998;12:663–668.
30. Wollensak G. Crosslinking treatment of progressive keratoconus: new hope.
CurrOpinOphthalmol. 2006;17:356–360.
31. Raiskup-Wolf F, Hoyer A, Spoerl E, et al.. Collagen crosslinking with riboflavin and
ultraviolet-A light in keratoconus: long-term results. J Cataract Refract Surg.
2008;34:796–801.
32. Wittig-Silva C, Whiting M, Lamoureux E, et al.. A randomized controlled trial of corneal
collagen cross-linking in progressive keratoconus: preliminary results. J Refract Surg.
2008;24:S720–S725.
http://annalsofrscb.ro 14353You can also read
